Skip to main content
OpenTrials

Clinical trial condition

Hepatitis, Chronic

Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.

1,281 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis, Chronic trial results

Completed

A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials

NCT01853254

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham, Alabama, United States
  • La Jolla, California, United States
  • Long Beach, California, United States
  • San Diego, California, United States
View all 67 locations
View Trial Details
Completed

A Phase 1 Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic Impairment

NCT01817985

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Investigational Site Miami, Florida, United States
  • Investigational Site Miami, Florida, United States
  • Investigational Site Orlando, Florida, United States
  • Investigational Site Orlando, Florida, United States
View Trial Details
Completed

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3

NCT00411385

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Scripps Clinic La Jolla, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • University of Colorado Denver, Colorado, United States
View all 159 locations
View Trial Details
Completed

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients

NCT00402428

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UCSF Fresno Fresno, California, United States
  • Scripps Clinic La Jolla, California, United States
View all 165 locations
View Trial Details
Completed

A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3

NCT00656006

Conditions
Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +26 more
Locations
  • University of Calgary Calgary, Alberta, Canada
  • University of Alberta Edmonton, Alberta, Canada
  • University of British Columbia Vancouver, British Columbia, Canada
  • University of Manitoba Winnipeg, Manitoba, Canada
View Trial Details
Completed

A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

NCT00623428

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham, Alabama, United States
  • La Jolla, California, United States
  • Lancaster, California, United States
  • Long Beach, California, United States
View all 101 locations
View Trial Details

Related conditions